Literature DB >> 25899569

Clinical spectrum of eye malformations in four patients with Mowat-Wilson syndrome.

A Bourchany1, I Giurgea2, J Thevenon3, A Goldenberg4, G Morin5, D Bremond-Gignac6, C Paillot7, P O Lafontaine7, D Thouvenin8, J Massy9, A Duncombe9, C Thauvin-Robinet3, A Masurel-Paulet3, S El Chehadeh3, F Huet1, A Bron7, C Creuzot-Garcher7, S Lyonnet10, L Faivre3.   

Abstract

Mowat-Wilson syndrome (MWS) is a rare genetic syndrome characterized by a specific facial gestalt, intellectual deficiency, Hirschsprung disease and multiple congenital anomalies. Heterozygous mutations or deletions in the zinc finger E-box-binding homeobox2 gene (ZEB2) cause MWS. ZEB2 encodes for Smad-interacting protein 1, a transcriptional co-repressor involved in TGF-beta and BMP pathways and is strongly expressed in early stages of development in mice. Eye abnormalities have rarely been described in patients with this syndrome. Herein, we describe four patients (two males and two females; mean age 7 years) with MWS and eye malformations. Ocular anomalies included, iris/retinal colobomas, atrophy or absence of the optic nerve, hyphema, and deep refraction troubles, sometimes with severe visual consequences. All eye malformations were asymmetric and often unilateral and all eye segments were affected, similarly to the nine MWS cases with ophthalmological malformations previously reported (iris/chorioretinal/optic disc coloboma, optic nerve atrophy, retinal epithelium atrophy, cataract, and korectopia). In human embryo, ZEB2 is expressed in lens and neural retina. Using the present report and data from the literature, we set out to determine whether or not the presence of eye manifestations could be due to specific type or location of mutations. We concluded that the presence of eye malformations, although a rare feature in MWS, should be considered as a part of the clinical spectrum of the condition.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  Mowat-Wilson; ZEB2; eye malformation; syndromic Hirschsprung disease

Mesh:

Substances:

Year:  2015        PMID: 25899569     DOI: 10.1002/ajmg.a.36898

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  4 in total

1.  A Novel Partial Duplication of ZEB2 and Review of ZEB2 Involvement in Mowat-Wilson Syndrome.

Authors:  Adrianne L Baxter; Jay L Vivian; R Tanner Hagelstrom; Waheeda Hossain; Wendy L Golden; E Robert Wassman; Rena J Vanzo; Merlin G Butler
Journal:  Mol Syndromol       Date:  2017-05-03

2.  Three Novel De Novo ZEB2 Variants Identified in Three Unrelated Chinese Patients With Mowat-Wilson Syndrome and A Systematic Review.

Authors:  Youqing Fu; Wanfang Xu; Qingming Wang; Yangyang Lin; Peiqing He; Yanhui Liu; Haiming Yuan
Journal:  Front Genet       Date:  2022-05-12       Impact factor: 4.772

3.  High-throughput custom capture sequencing identifies novel mutations in coloboma-associated genes: Mutation in DNA-binding domain of retinoic acid receptor beta affects nuclear localization causing ocular coloboma.

Authors:  Vijay K Kalaskar; Ramakrishna P Alur; LeeAnn K Li; James W Thomas; Yuri V Sergeev; Delphine Blain; Robert B Hufnagel; Tiziana Cogliati; Brian P Brooks
Journal:  Hum Mutat       Date:  2019-12-09       Impact factor: 4.878

4.  A de novo triplication on 2q22.3 including the entire ZEB2 gene associated with global developmental delay, multiple congenital anomalies and behavioral abnormalities.

Authors:  Haiming Yuan; Lina Zhang; Mengfan Chen; Junping Zhu; Zhe Meng; Liyang Liang
Journal:  Mol Cytogenet       Date:  2015-12-23       Impact factor: 2.009

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.